i-Base home
Search Menu
  • Home
  • HTB
  • 2018
  • May
  • 21

21 May 2018

Contents

Editorial

  • 21 May 2018: vol 19 no 9: DTG Alert and BHIVA/BASHH reports

Treatment alerts

  • Potential safety signal for dolutegravir from the time of conception

Conference reports

  • Fourth Joint Conference of BHIVA/BASHH (4th BHIVA/BASHH)
  • Low PEP and PrEP awareness among trans people in London and their partners
  • Low awareness of PrEP in BME communities in Leeds but high interest in use
  • Younger people living with HIV more likely to have a positive self image
  • Zero or negligible risks of HIV, HBV or HCV transmission by biting or spitting
  • UK-CAB community representation on guideline panels and research studies

Treatment access

  • Phase 3 registrational data is not sufficient for roll-out of new ARVs in low- and middle-income countries
  • Generic manufacturers from South Africa and South Korea join Medicine Patent Pool (MPP)
  • WHO releases first list for essential diagnostics
  • Campaign forces Government U-turn on linking NHS data to immigration service

Pregnancy

  • Dolutegravir in pregnancy: early data reassuring but ongoing surveillance is still essential

Paediatric care

  • FDA guidance for developing paediatric ARVs: online for comment (2018)

Coinfections and complications

  • US study tracks kidney transplant results from HIV positive donors

Basic science and immunology

  • New online animation of HIV lifecycle

Other news

  • St Stephen’s AIDS Trust to close after 30 years of HIV research

PDFs

  • 21 May 2018: vol 19 no 9
  • HTB RSS

Early access

  • Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news 4 May 2025
  • The RIO study: Q&A about controlling HIV with bNAbs 21 April 2025
  • Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years 20 April 2025
  • Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs 13 April 2025
  • All early access reports

Current issues

  • May 2025
  • April 2025
  • March 2025
  • Back issues

Special report

  • Reduced dosing: a possible crisis response to ART stockouts and closed clinics 5 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook